According to Horizon Therapeutics 's latest financial reports the company's current revenue (TTM) is $3.64 B. In 2022 the company made a revenue of $3.62 B an increase over the years 2021 revenue that were of $3.22 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.64 B | 0.42% |
2022 | $3.62 B | 12.48% |
2021 | $3.22 B | 46.63% |
2020 | $2.20 B | 69.26% |
2019 | $1.30 B | 7.66% |
2018 | $1.20 B | 14.33% |
2017 | $1.05 B | 7.66% |
2016 | $0.98 B | 29.6% |
2015 | $0.75 B | 154.94% |
2014 | $0.29 B | 301.2% |
2013 | $74.01 M | 277.02% |
2012 | $19.63 M | 183.41% |
2011 | $6.92 M | 191.54% |
2010 | $2.37 M | |
2009 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $77.94 B | 2,038.73% | ๐บ๐ธ USA |
![]() Amgen AMGN | $26.58 B | 629.39% | ๐บ๐ธ USA |
![]() Merck MRK | $58.31 B | 1,500.01% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $44.48 B | 1,120.61% | ๐ฌ๐ง UK |
![]() Dr. Reddy's RDY | $3.17 B | -12.74% | ๐ฎ๐ณ India |